linkedin gif

+33 1 42 54 60 64
Login & Registration

Home >  EU Funding news >  News

Monday, February 26, 2007

Strengthening medicines safety monitoring

Research, Health, Industry,Research centres,Corporations,SMEs,Universities,

News A public consultation shows that the current EU system of medicines safety monitoring (pharmacovigilance) needs rationalisation and strengthening.

The current EU legal framework is complex and duplicative and there is a need to clarify roles and responsibilities. Differing implementation by Member States has led to complex and diverse reporting requirements for the industry and decision-making at EU-level is overly complicated. Commission Vice-President Günter Verheugen today announced a strengthening of the EU pharmacovigilance system. The proposals focus on clarifying the roles and responsibilities for pharmacovigilance, simplifying reporting rules and ensuring that robust safety studies are carried out to support rapid EU decision-making. These reforms will provide better public health protection and the safe use of new and innovative medicines.

Source : 

More information  DG Entreprise




28 June - 20 September 2019, Online consultation
24 September - 26 September 2019, Brussels
26 September, Brussels
15 October - 16 October 2019, Brussels


Welcomeurope, 161 rue Montmartre, 75002 Paris | Tél . : +33 1 42 54 60 64 / Fax : +33 1 42 54 70 04

© Welcomeurope 2000-2018

Welcome to This site uses cookie to improve the analysis of the website and the quality of services. By using our site, you agree to use the cookies. More